About Zenovel
Zenovel is a global leader in providing affordable, innovative, and high-quality solutions to the pharmaceutical industry. With over 20 years of expertise
We focus on delivering a one-stop solution to help safe and effective medicines reach the market. Our services include GCP & GMP monitoring and auditing, Regulatory Affairs, Sponsor Oversight, QMS management, Training, Pre-clinical support, CSV, and drug development and discovery services.
Zenovel’s strength lies in its team of experts, who combine their knowledge, skills, and ethical commitment to client success. We value integrity, wisdom, and innovation—creating a dynamic approach to address healthcare challenges and regulatory complexities.
- Decoding Zenovel: ZEN + NOVEL
- Zen
Embodies core values like integrity, wisdom, compassion, and generosity, ensuring our work
is grounded in ethics and client trust.
- NOVEL
Reflects our commitment to constant improvement, innovation, and a forward-thinking
mindset. We are driven by knowledge, experience, and timebound commitments.
Through a combination of vertical integration & a proactive client-centric approach, Zenovel has built a reputation as a trusted partner in the pharmaceutical space. We offer tailored GCP & GMP services, regulatory support, & auditing for pharmaceutical development globally.
- Through vertical integration, Zenovel provides expert services in,
- Independent Audit & Monitoring in Clinical Research (GCP)
Pre-Clinical, BA/BE, Clinical Trial-
Monitoring/Auditing/Training/PK etc.
- GMP Audits and Monitoring
Audits of API, Excipients, finished products facilities, Greenfield projects of plant set up, GAP/ QMS Audits, Support in regulatory inspections
- Regulatory Services
Dossier (CTD) Preparation and review, e-CTD and procedure management, Clinical & Non-clinical overview write up, User testing
Zenovel’s global network of auditors and consultants supports over 250 clients across 45 countries, helping them overcome regulatory challenges and reach their goals faster. By simplifying the complex regulatory processes, we allow our clients to focus on what truly matters—bringing safe, effective treatments to patients in need.
- From Rakesh Sutariya, MD & CEO
“At Zenovel, we believe in going beyond compliance. Our philosophy centers on innovation, collaboration, and ethical integrity. We don’t just offer services; we deliver solutions that make a real difference in advancing healthcare. By simplifying regulatory complexities, we empower our clients to focus on innovation, ensuring safe and effective treatments reach patients. As we continue to expand globally, our unwavering commitment to ethics and quality drives us forward, making a meaningful impact on healthcare around the world.”
- Our Purpose
At Zenovel, we strive for “quality beyond compliance”. This means we don’t just meet the industry’s
regulatory standards; we consistently aim to exceed them. Our focus is on delivering the highest level of
excellence in GCP, GMP, and regulatory services. We go beyond the checklists and audits to ensure every
project is handled with precision, integrity, and innovation. By continuously improving our processes and
adopting cutting-edge technologies, we ensure that our clients not only comply with regulations but also
lead in delivering quality healthcare solutions.
- Mission
Our mission is to provide the most reliable and preferred service platform to pharmaceutical companies
worldwide for research and development cycle, regulatory affairs and GMP compliance with higher
benchmark of quality, integrity and ethics.
Our mission is to enjoy the journey with best efforts towards achieving the end points with value driven approach.
We believe in core values of superior quality, transparency, ethical approach, confidentiality, zero conflict
of interest, accountability, honesty and constant improvement.
- Vision
With our innate passion we are inspired to become the most trusted brand and reliable partner for pharmaceutical companies globally.
We inspire to become the synonym for quality, integrity, reliability in the mind of our clients when it comes to outsource their need in GCP, Regulatory Affairs and GMP.
We have set our vision with our passion to create an ecosystem where the teams of experts working towards get the best ground to bring out the best of their potential and divert it for the common end point of quality deliverables with in framed timelines.
- Values
- Trust and Transparency
- Integrity and Reliability
- Speed and Timely Delivery
- Best Quality and Total Compliance
- Team work and Commitment
- Innovation and Creativity
- Culture
At Zenovel, Teamwork and Transparency is at the core of our work culture. We believe in the power of
collaboration, where every individual’s expertise is valued and shared toward achieving common goals.
Our teams work cohesively, leveraging diverse skills and experiences to overcome challenges and deliver
high-quality solutions.
We foster a supportive environment that encourages open communication, accountability, and mutual respect, ensuring that all team members contribute meaningfully. This collaborative spirit drives innovation and empowers us to consistently deliver excellence to our clients and partners.
- Founder
Rakesh Sutariya is the visionary Managing Director and CEO of Zenovel, bringing over 17 years of expertise in strategic marketing, operation management, business development, bio-analytical, clinical, and IT fields. He has successfully monitored, audited, and conducted over 1,000 clinical trials, while helping design and execute complex studies for regulatory submissions. Under his leadership, Zenovel has served over 150 global clients across 45 countries, supporting pharmaceutical development through GCP, GMP, and regulatory services. His leadership at Zenovel is marked by his hands-on approach, overseeing team and collaborating closely with various departments to ensure the company’s growth and success.
Mr. Rakesh Sutariya’s philosophy on quality of work is deeply rooted in the principles of integrity, precision, and continuous improvement. He believes that true success lies in delivering services that not only meet but exceed client expectations. Under his leadership, Zenovel has adopted a client-first approach, focusing on personalized solutions tailored to the unique needs of each project. He emphasizes the importance of building long-term relationships based on trust, transparency, and accountability, ensuring that clients remain well-informed at every stage of the process.
His approach to quality is driven by a commitment to ethical practices and maintaining the highest standards in every aspect of operations. For Mr. Rakesh, “Quality is not just about achieving results—it’s about doing so in a way that aligns with Zenovel’s core values of compassion, wisdom, and excellence”. He believes in empowering his team through continuous learning and development, ensuring they stay at the forefront of industry innovations while maintaining a keen focus on regulatory compliance.
- From Rakesh Sutariya, MD & CEO:
“At Zenovel, we believe in going beyond compliance. Our philosophy centers on innovation, collaboration, and ethical integrity. We don’t just offer services; we deliver solutions that make a real difference in advancing healthcare. By simplifying regulatory complexities, we empower our clients to focus on innovation, ensuring safe and effective treatments reach patients. As we continue to expand globally, our unwavering commitment to ethics and quality drives us forward, making a meaningful impact on healthcare around the world.”
Mr. Rakesh’s client approach is proactive and collaborative. He views every client partnership as an extension of Zenovel’s mission to deliver safe, effective, and reliable pharmaceutical solutions. His philosophy centers on providing tailored, cost-effective services, and fostering open communication, ensuring that clients feel supported throughout their journey.
With presence in almost 6 countries world-wide including India, Canada, Malaysia, China, USA, Australia we bring world together.
Life @ Zenovel
Blogs and news
Our Latest Article
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is the
Lipinski’s Rule of 5 (Ro5) is a crucial guideline in pharmaceutical development, helping researchers evaluate a compound’s likelihood of becoming an effective oral drug. However, with the rapid evolution of therapeutic strategies, it’s worth considering the relevance of Ro5 in the current drug design landscape. Understanding Lipinski’s Rule of 5
Regulatory affairs (RA) play a crucial role in the pharmaceutical industry; ensuring products meet quality, safety, and efficacy. As the industry grow further the need for qualified professionals to bridge gaps between companies and regulators increases. This blog explores Zenovel regulatory affairs expertise, our various facets, and valuable contribution to
Navigating the world of pharmaceuticals, medical devices, and biotechnology is never straightforward. With the diversity of regulatory compliance governs the Code of Federal Regulations (CFR) – a regulatory path that shapes companies’ efforts and implements how companies long for their products to be developed, manufactured, and marketed. For companies trying
The race to deliver life-saving therapies to patients is increasingly faster and more complex. Pharmaceutical and biotech companies are faced with a dizzying list of challenges — global clinical trials, continuously changing regulations, multiple complicated therapeutic areas, and pressure to innovate. This is where Contract Research Organizations (CRO) come in:
